PBYI

PUMA BIOTECHNOLOGY, INC.

PBYI · CIK 1401667 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$228M
20182025
Net Income$31M
20182025
Operating CF$42M
20182025
Free Cash Flow$42M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.2B$0.2B$0.2B$0.2B$0.3B$0.1B$0.1B$0.1B
Cost of Revenue$0.1B$0.1B$0.1B$0.1B$0.1B——$0.0B
Gross Profit————————
R&D Expense————$0.1B$0.1B$0.1B$0.2B
SG&A Expense$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Operating Income$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B$-0.0B$-0.1B
Net Income$0.0B$0.0B$0.0B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$0.62$0.62$0.46$0.00$-29126.00$-0.38——
EPS (Diluted)$0.61$0.62$0.45$0.00—$-0.38——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.2B$0.2B$0.2B$0.2B$0.2B$0.2B$0.2B$0.3B
Current Assets$0.2B$0.1B$0.2B$0.1B$0.1B$0.1B$0.2B$0.2B
Cash & Equivalents$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Total Liabilities$0.1B$0.1B$0.2B$0.2B$0.2B$0.3B$0.2B$0.2B
Current Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$0.1B$0.1B$0.1B$0.0B$-0.0B$-0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.0B$0.0B$0.0B$-0.0B$0.0B$0.0B$0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$0.0B$-0.0B$0.0B$0.0B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B——$0.0B
Financing Cash Flow$-0.0B$-0.0B$0.0B$0.0B$-0.0B$0.0B$-0.1B$0.1B
← Companies